SERS Nanocomposites for Targeted Cancer Drug Delivery Detection
Solution Overview
Problem
Existing nano-sized systems for cancer diagnosis and treatment lack multifunctional, tunable characteristics such as controllable surface chemistry, stability in liquid environments, non-toxicity, and the ability to generate unique and intense signals for high-resolution detection and delivery of drugs to cancer cells.
Innovation Solution
Development of plasmonically active silver-decorated gold nanorods (AuNR/Ag) conjugated with doxorubicin and anti-EpCAM or Docetaxel antibodies, which provide unique Raman spectroscopic properties for targeted drug delivery and detection, using a multitude of drug delivery vehicles with different antibodies for enhanced cancer treatment.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Adaptability or versatility
If conventional nanoparticles (polymers, liposomes, viruses, micelles, dendrimers, carbon nanotubes, graphene, metallic nanoparticles) are used for drug delivery, then the system can deliver drugs to cancer cells, but the system lacks multifunctional characteristics including controllable surface chemistry, stability in liquid environments, non-toxicity, and ability to generate unique intense signals for high-resolution detection
Solution Approach 1:
The patent combines multiple functional components into a single nanocomposite system: gold nanorods provide photothermal conversion and structural stability, silver nanoparticles enhance SERS signal detection, polyethylene glycol shell provides biocompatibility and stability in liquid environments, and surface-functionalized antibodies enable specific cancer cell targeting. This merging of multiple functionalities into one system resolves the contradiction by achieving both versatility and reliability simultaneously.
Solution Approach 2:
The invention uses composite nanomaterials with core-shell structure (gold nanorod core, silver nanoparticle decoration, polyethylene glycol shell) that integrate multiple properties: the gold core provides photothermal stability, the silver shell enhances optical detection signals, and the polymer shell provides chemical stability and biocompatibility in liquid physiological environments, thus achieving both multifunctionality and environmental stability.
2Measurement precision
If conventional nanoparticles are used for cancer detection, then the system can provide basic imaging, but the system cannot generate unique and intense signals for high-resolution detection and visualization
Solution Approach 1:
The patent changes the optical parameters of the nanomaterials by using gold nanorods with specific aspect ratios that exhibit localized surface plasmon resonance at near-infrared wavelengths, and decorating with silver nanoparticles that enhance Raman scattering cross-sections. These parameter changes enable the system to generate intense, unique SERS signals that can be detected with high spatial resolution, directly improving measurement precision.
Solution Approach 2:
The patent replaces conventional imaging methods with surface-enhanced Raman scattering (SERS) spectroscopy, which uses electromagnetic field enhancement at the nanoscale to generate highly sensitive molecular fingerprints. This substitution enables detection at much lower concentrations and with higher spatial resolution than conventional imaging techniques, achieving both high signal intensity and precise measurement.
3Reliability
If conventional drug delivery systems are used, then the system can deliver drugs, but the system lacks specific targeting capability and cannot confirm interactions with cancer cells
Solution Approach 1:
The patent incorporates SERS-active molecular probes on the nanocomposite surface that serve as optical reporters. When the nanocomposite binds to cancer cells, the SERS signal changes provide real-time feedback confirmation of the interaction. This feedback mechanism allows researchers to verify specific targeting and binding events, preventing loss of information about cell-nanoparticle interactions.
Solution Approach 2:
The patent uses SERS spectroscopy which detects unique vibrational frequencies (molecular fingerprints) of the nanocomposite and its interactions with cellular components. The characteristic Raman shift changes upon binding to cancer cells provide a spectral 'color change' that confirms specific interactions, enabling reliable detection of targeting specificity without losing interaction information.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables accurate detection and quantification of drug delivery to cancer cells, enhancing cancer treatment by synergistic drug delivery and providing strong signals for visualization and confirmation of interactions with cells.
Implementation Method 1
plasmonically active silver-decorated gold nanorods (AuNR/Ag)
Implementation Method 2
anti-EpCAM or Docetaxel antibodies
Data Source
AI summary
A nanoagent for detections and treatments of multiple targets of interest includes multiple types of nanocomposites, each type of nanocomposites comprising at least one nanostructure, each nanostructure having a core and a shell surrounding the core; a respective reporter assembled on the shell of each nanostructure; and a layer of a respective treating agent and a respective targeting agent conjugated to the respective reporter. In use, each type of nanocomposite targets to a respective target of interest according to the respective targeting agent and releases the respective treating agent and the nanostructure therein for therapeutic treatment of the respective target of interest, and the respective target of interest transmits at least one signature responsive to the respective reporter for detection of the respective target of interest.